よむ、つかう、まなぶ。

MC plus(エムシープラス)は、診療報酬・介護報酬改定関連のニュース、

資料、研修などをパッケージした総合メディアです。


「日本人の食事摂取基準(2025年版)」策定検討会報告書 (471 ページ)

公開元URL https://www.mhlw.go.jp/stf/newpage_44138.html
出典情報 「日本人の食事摂取基準(2025年版)」策定検討会報告書(10/11)《厚生労働省》
低解像度画像をダウンロード

資料テキストはコンピュータによる自動処理で生成されており、完全に資料と一致しない場合があります。
テキストをコピーしてご利用いただく際は資料と付け合わせてご確認ください。

56) Li Q, Wen F, Wang Y, et al. Diabetic kidney disease benefits from intensive low-protein diet: Updated
systematic review and meta-analysis. Diabetes Ther. 2021;12(1):21-36.
57) 日本糖尿病学会編. 糖尿病治療ガイド 2022-2023. 文光堂; 2022.
58) 日本糖尿病学会編. 糖尿病診療ガイドライン 2019. 南江堂; 2019.
59) Ruggenenti P, Abbate M, Ruggiero B, et al. Renal and systemic effects of calorie restriction in patients with
type 2 diabetes with abdominal obesity: A randomized controlled trial. Diabetes. 2017;66(1):75-86.
60) 山内敏正, 神谷英紀, 宇都宮一典, 他. 糖尿病患者の栄養食事指導―エネルギー・炭水化物・タン
パク質摂取量と栄養食事指導―. 糖尿病. 2020;63(3):91-109.
61) Tauchi E, Hanai K, Babazono T. Effects of dietary protein intake on renal outcome and mortality in patients
with advanced diabetic nephropathy. Clin Exp Nephrol. 2020;24(2):119-125.
62) Nezu U, Kamiyama H, Kondo Y, et al. Effect of low-protein diet on kidney function in diabetic nephropathy:
meta-analysis of randomised controlled trials. BMJ Open. 2013;3(5):e002934.
63) Sohouli MH, Mirmiran P, Seraj SS, et al. Impact of low-protein diet on cardiovascular risk factors and
kidney function in diabetic nephropathy: A systematic review and meta-analysis of randomized-controlled
trials. Diabetes Res Clin Pract. 2022;191:110068.
64) Chaturvedi S, Jones C. Protein restriction for children with chronic renal failure. Cochrane Database Syst
Rev. 2007;(4):CD006863.
65) Korgaonkar S, Tilea A, Gillespie BW, et al. Serum potassium and outcomes in CKD: insights from the RRICKD cohort study. Clin J Am Soc Nephrol. 2010;5(5):762-769.
66) Kashihara N, Kohsaka S, Kanda E, et al. Hyperkalemia in real-world patients under continuous medical care
in Japan. Kidney Int Rep. 2019;4(9):1248-1260.
67) Kalantar-Zadeh K, Gutekunst L, Mehrotra R, et al. Understanding sources of dietary phosphorus in the
treatment of patients with chronic kidney disease. Clin J Am Soc Nephrol. 2010;5(3):519-530.
68) Isakova T, Barchi-Chung A, Enfield G, et al. Effects of dietary phosphate restriction and phosphate binders
on FGF23 levels in CKD. Clin J Am Soc Nephrol. 2013;8(6):1009-1018.
69) Chang AR, Miller ER 3rd, Anderson CA, et al. Phosphorus additives and albuminuria in early stages of
CKD: A randomized controlled trial. Am J Kidney Dis. 2017;69(2):200-209.
70) Scialla JJ, Appel LJ, Wolf M, et al. Plant protein intake is associated with fibroblast growth factor 23 and
serum bicarbonate levels in patients with chronic kidney disease: the Chronic Renal Insufficiency Cohort
study. J Ren Nutr. 2012;22(4):379-388.e1.
71) Yoshioka M, Kosaki K, Matsui M, et al. Association between the intake of plant and animal proteins and
the serum fibroblast growth factor-23 level in patients with chronic kidney disease analyzed by the isocaloric
substitution model. Endocr J. 2023;70(1):31-42.
72) Stremke ER, McCabe LD, McCabe GP, et al. Twenty-four-hour urine phosphorus as a biomarker of dietary
phosphorus intake and absorption in CKD: A secondary analysis from a controlled diet balance study. Clin
J Am Soc Nephrol. 2018;13(7):1002-1012.
73) Ix JH, Anderson CAM, Smits G, et al. Effect of dietary phosphate intake on the circadian rhythm of serum
phosphate concentrations in chronic kidney disease: a crossover study. Am J Clin Nutr. 2014;100(5):13921397.

461